Bio Connections Australia 2021

AUM Biosciences contributed information as an experienced company in global clinical trials at the Bio Connections Australia 2021 Conference. This event brings together a group of leading experts in the biotech and pharmaceutical industries to cover topics such as commercialisation of novel therapeutic research and increasing global outreach.

AUM Biosciences, a global clinical-stage biopharmaceutical company with a focus on discovering, acquiring, and developing novel targeted therapeutics in oncology, is pleased to announce that Dr. John Patava, Chief Operating Officer, participated in an expert panel focused on answering the different ways Australia can become a global clinical trials player hosted by Informa connect on Thursday, November 18th.

To access the conference, please registerHERE

About AUM Biosciences

AUM Biosciences is a global clinical stage biotech company, focused on discovering and developing novel targeted oncology therapies, particularly for cancers with a clear genetic marker. The management team has an extensive track record of selecting distinctive early stage assets, successfully exiting virtual biotech models, and have contributed significantly to the development of several currently marketed oncology treatments with annual peak sales up to $3B. AUM was founded to enable a holistic strategy for drug development and improving the probability of success with a focus on synergism, sustainability and scalability.

For more information, please visit